This 1.5-hour symposium will feature nationally recognized leaders in the management of atherosclerotic cardiovascular disease (ASCVD) risk, sharing the latest evidence and clinical practice pearls with managed care pharmacists.
The program will include an introduction to the new 2018 Blood Cholesterol guides, examining what is new, and discussing the management algorithm for primary and secondary prevention.
Presentations will also provide detailed information on recent CVD outcomes trials, especially those that have proven benefits and provide new options for ASCVD management.
A perspective for the managed care pharmacist, incorporating the guidelines, recent data, and managed care implications, will give attendees an educated framework for their decision making in this area.
Relevant clinical practice issues and challenges will also be addressed.